GSK Latest Headlines

Trump nominates Erica Schwartz to lead CDC, ending months-long search

at seekingalpha.com (Fri, 17-Apr 3:28 AM)

GSK’s New Pneumonia Vaccine Trial Targets a Growing Adult Market

at www.tipranks.com (Thu, 16-Apr 12:34 PM)

Alector gains as Cantor Fitzgerald upgrades on brain carrier platform

at seekingalpha.com (Wed, 15-Apr 11:10 AM)

White House reportedly eyeing former deputy surgeon general to lead CDC

at seekingalpha.com (Wed, 15-Apr 7:20 AM)

GlaxoSmithKline (GSK) Gets a Hold from Deutsche Bank

at www.tipranks.com (Tue, 14-Apr 5:05 AM)

Barclays Reaffirms Their Sell Rating on GlaxoSmithKline (GSK)

at www.tipranks.com (Tue, 14-Apr 2:36 AM)

GlaxoSmithKline (GSK) Gets a Hold from Citi

at www.tipranks.com (Tue, 14-Apr 1:57 AM)

J.P. Morgan Keeps Their Sell Rating on GlaxoSmithKline (GSK)

at www.tipranks.com (Mon, 13-Apr 5:36 AM)

GlaxoSmithKline (GSK) Receives a Buy from Jefferies

at www.tipranks.com (Mon, 13-Apr 5:36 AM)

“A Blockbuster? Yes, Absolutely” — GlaxoSmithKline (GSK) Stock Slides despite Morez Hype

at www.tipranks.com (Mon, 13-Apr 5:33 AM)

Goldman Sachs Sticks to Their Hold Rating for GlaxoSmithKline (GSK)

at www.tipranks.com (Mon, 13-Apr 4:38 AM)

GSK bets big on cancer comeback with aggressive trial push

at seekingalpha.com (Sun, 12-Apr 4:24 PM)

GSK’s AREXVY RSV Vaccine Gains US Approval for 18–49-Year-Olds at Risk: A Significant Step in Adult RSV Protection

Market Chameleon (Mon, 16-Mar 7:53 AM)

GSK’s AREXVY Shows 75.6% Effectiveness in Reducing RSV Hospitalizations and Related Health Risks in Real-World Study

Market Chameleon (Wed, 18-Feb 8:31 AM)